Furthermore, although the tumours we originally described in POLE and POLD1 carriers were microsatellite-stable, the frequency of MSI (12.5%) that we now describe in CRCs is similar to that in sporadic CRCs, despite the earlier onset of the former. The gene discussed is POLE; the disease is neoplasm.